Exact Mass: 876.4745

Exact Mass Matches: 876.4745

Found 7 metabolites which its exact mass value is equals to given mass value 876.4745, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Spinorphin

(2S,3R)-2-{[(2S)-2-({[(2S)-1-[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-hydroxybutanoic acid

C45H64N8O10 (876.4745)


Spinorphin is an endogenous opioid heptapeptide that has the amino acid sequence Leu-Val-Val-Tyr-Pro-Trp-Thr (LVVYPWT). It has been observed to possess antinociceptive, antiallodynic and anti-inflammatory properties. The mechanism of action of spinorphin has not been fully elucidated but it has been found to act as an antagonist of the P2X3 receptor,[5] and as a weak partial agonist/antagonist of the FP1 receptor.

   

Neoviridogrisein I

Neoviridogrisein I

C45H64N8O10 (876.4745)


   
   
   

(2r,3s)-2-({[(3s,6r,9s,12s,15s)-3-benzyl-2,5,11,14-tetrahydroxy-6-(2-{2-[(hydroxymethylidene)amino]phenyl}-2-oxoethyl)-12-isopropyl-7-methyl-9-(2-methylpropyl)-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylpentanoic acid

(2r,3s)-2-({[(3s,6r,9s,12s,15s)-3-benzyl-2,5,11,14-tetrahydroxy-6-(2-{2-[(hydroxymethylidene)amino]phenyl}-2-oxoethyl)-12-isopropyl-7-methyl-9-(2-methylpropyl)-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylpentanoic acid

C45H64N8O10 (876.4745)


   

n-[(6s,9s,12s,15r,16s,19r,24ar)-9-ethyl-7,17-dihydroxy-2,5,11,15-tetramethyl-6-(3-methylbutan-2-yl)-19-(2-methylpropyl)-1,4,10,13,20-pentaoxo-12-phenyl-3h,6h,9h,12h,15h,16h,19h,22h,23h,24h,24ah-pyrrolo[2,1-o]1-oxa-4,7,10,13,16,19-hexaazacyclodocosan-16-yl]-3-hydroxypyridine-2-carboximidic acid

n-[(6s,9s,12s,15r,16s,19r,24ar)-9-ethyl-7,17-dihydroxy-2,5,11,15-tetramethyl-6-(3-methylbutan-2-yl)-19-(2-methylpropyl)-1,4,10,13,20-pentaoxo-12-phenyl-3h,6h,9h,12h,15h,16h,19h,22h,23h,24h,24ah-pyrrolo[2,1-o]1-oxa-4,7,10,13,16,19-hexaazacyclodocosan-16-yl]-3-hydroxypyridine-2-carboximidic acid

C45H64N8O10 (876.4745)


   

(2r,3r)-2-({[(3s,6r,9s,12s,15s)-3-benzyl-2,5,11,14-tetrahydroxy-6-(2-{2-[(hydroxymethylidene)amino]phenyl}-2-oxoethyl)-12-isopropyl-7-methyl-9-(2-methylpropyl)-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylpentanoic acid

(2r,3r)-2-({[(3s,6r,9s,12s,15s)-3-benzyl-2,5,11,14-tetrahydroxy-6-(2-{2-[(hydroxymethylidene)amino]phenyl}-2-oxoethyl)-12-isopropyl-7-methyl-9-(2-methylpropyl)-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-methylpentanoic acid

C45H64N8O10 (876.4745)